Menu Search
Equities

DSM-Firmenich AG

ZX6:DUS

DSM-Firmenich AG

Actions
  • Price (EUR)103.85
  • Today's Change-1.50 / -1.42%
  • Shares traded20.00
  • 1 Year change+17.03%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 13:20 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

DSM-Firmenich AG, formerly Danube AG is a Switzerland based company, which is active in nutrition, health, and beauty industry. The Company operates in four complementary businesses Perfumery & Beauty, which offer perfumery, fragrance ingredients and personal and care aroma; Taste, Texture & Health, which produces nutritional products with natural flavours and ingredients; Health, Nutrition & Care division offers customized products that contain vitamins, nutritional lipids, digestive enzymes, probiotics and cannabinoids (CBD); Animal Nutrition & Health business offers customer tailored products, solutions and services for animal farming that contain vitamins, animal proteins, carotenoids and premixes. The Company operates worldwide.

  • Revenue in EUR (TTM)--
  • Net income in EUR--
  • Incorporated2022
  • Employees27.93k
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.